SCHEMBL31301355

SCHEMBL31301355

CCc1ccc(-n2cnc(C(=O)N(C)c3ccc(C)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 1/20 0.40
ALOX15B O15296 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TP53 P04637 2/20 0.38
GPBAR1 Q8TDU6 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HCRTR2 O43614 1/20 0.37
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
NOTUM Q6P988 1/20 0.37
ACKR3 P25106 1/20 0.36
ALOX15 P16050 1/20 0.35
NAMPT P43490 1/20 0.35
HSD17B1 P14061 1/20 0.34
HSD17B2 P37059 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31301351 0.91 MAPT (0.43) ALDH1A1KMT2AMAPTSMN1; SMN2TP53
SCHEMBL31301349 0.89 GPBAR1 (0.43) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL31301267 0.89 GPBAR1 (0.43) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL31301475 0.87 TP53 (0.38) ALDH1A1MAPTSMN1; SMN2TP53GPBAR1
SCHEMBL31301534 0.87 MCHR1 (0.43) ALDH1A1MAPTSMN1; SMN2TP53GPBAR1
SCHEMBL31301487 0.85 GPBAR1 (0.46) MEN1KMT2AMAPTSMN1; SMN2TP53
SCHEMBL31301570 0.85 TP53 (0.45) MEN1KMT2AMAPTSMN1; SMN2TP53
SCHEMBL31301506 0.85 GPBAR1 (0.46) MEN1KMT2AMAPTSMN1; SMN2TP53
SCHEMBL31301466 0.85 MAPT (0.49) ALDH1A1MEN1ALOX15BHPGDKMT2A
SCHEMBL31301593 0.85 MAPT (0.52) ALDH1A1MEN1ALOX15BHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS UNIV GEORGIA (US) 2026-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260097046-A1 PLASMODIUM FALCIPARUM BLOOD STAGE INHIBITORS SUB1, PFN1, HCCS ALDH1A1 3257/4885MEN1 4439/4885ALOX15B 1560/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.